ABSTRACT
The pharmaceutical industry is on the verge of an exciting and challenging century. Advances in pharmaceutical sciences have dramatically changed the processes of discovery and development of new therapeutic drugs and, in turn, resulted in an extraordinary increase in the potential prophylactic and therapeutic interventions. In this atmosphere, an
TABLE OF CONTENTS
part |2 pages
PART I Preparation for Clinical Trials
part |2 pages
PART II Regulatory Organization and Decision Making
part |2 pages
PART III Evaluation and Quality Assurance of Drugs and Biopharmaceuticals
part |2 pages
PART IV Assessment of Cardiovascular Drugs
part |2 pages
PART V Assessment of Respiratory Drugs
part |2 pages
PART VI Assessment of Central Nervous System Drugs
part |2 pages
PART VII Assessment of Gastrointestinal and Liver Drugs
part |2 pages
PART VIII Assessment of Genitourinary Drugs
part |2 pages
PART IX Assessment of Skin Drugs
part |2 pages
PART X Assessment of Metabolism Drugs
part |2 pages
PART XI Assessment of Chemotherapeutic Drugs
part |2 pages
PART XII Assessment of Antiinflammatory and Pain Drugs
part |2 pages
PART XIII Assessment of Biopharmaceuticals
part |2 pages
PART XIV Future Perspective
